HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 22, No 01, January 2018 – Weighing the options       » Scientists close in on origin of SARS       » Chinese researchers map key protein in DNA repair with near-atomic resolution       » Ryzodeg reduces hypoglycaemia in type 2 diabetic fasting patients       » United States cancer drug costs increasing despite competition       » Eating yogurt may help reduce chronic inflammation in women      
INSIDE INDUSTRY
Asia-Pacific, the rising region for cancer vaccine clinical trials
North America takes the lead with the highest percentage of cancer vaccine clinical trials but Asia-Pacific is rising, especially with the Chinese government’s recent proposal on a new regulatory process for drug approvals.

The North America and Asia-Pacific regions had the highest number of cancer vaccine clinical trials initiated between 2007 and 2016, according to a recent study by GlobalData, a data and analytics company.

Considering that many of the top companies in the pharma industry are headquartered in North America, it will come as no surprise that this region had the highest percentage of cancer vaccine clinical trials at 47 per cent.

However, a spokesperson from the Healthcare Analysts Team at GlobalData commented, ‘’With the recent news of the Chinese government’s proposal to adopt a new regulatory process for drug approvals, thus opening up the market to big pharma, Asia-Pacific’s second highest share of 33 per cent can only increase in the coming years.’’

In third place, the Europe Region with 16 per cent of all cancer vaccine trials initiated over the ten-year period. The South and Central American Region and the Middle East and African regions take fourth place each with 2 per cent respectively.

Source: GlobalData

Click here for the complete issue.

NEWS CRUNCH  
news Biology of Ageing II - Impactful Interventions
news Separation of conjoined twins presents surgical and ethical challenges for MassGeneral Hospital for Children staff
news MIT Technology Review announces 2018's 10 'Innovators Under 35 Asia'
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Addressing the ageing population / Clinical trials
March:
Nutrition / Women in Science
April:
Digestive health / Intellectual property
May:
Asthma / Dental health
June:
Oncology / Biotech landscape in APAC
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy